125 related articles for article (PubMed ID: 34951409)
1. TEAD4 overexpression suppresses thyroid cancer progression and metastasis
Zhang B; Wang Q; Ji Y; Zhang X; Xue L; Shi Q; Li J
J Biosci; 2022; 47():. PubMed ID: 34951409
[TBL] [Abstract][Full Text] [Related]
2. TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.
Zhang Q; Fan H; Zou Q; Liu H; Wan B; Zhu S; Hu Y; Li H; Zhang C; Zhou L; Zhu Q; Xiao K; Zhang J; Zhan P; Lv T; Song Y
J Cell Mol Med; 2018 Jul; 22(7):3560-3571. PubMed ID: 29667772
[TBL] [Abstract][Full Text] [Related]
3. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
[TBL] [Abstract][Full Text] [Related]
4. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
[TBL] [Abstract][Full Text] [Related]
5. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
7. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J
J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693
[TBL] [Abstract][Full Text] [Related]
9. MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer.
Li Q; Tong D; Jing X; Ma P; Li F; Jiang Q; Zhang J; Wen H; Cui M; Huang C; Zhang M
Cancer Gene Ther; 2023 May; 30(5):727-737. PubMed ID: 36599972
[TBL] [Abstract][Full Text] [Related]
10. TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer.
Tong X; Liu YS; Tong R; Tang WW; Li XM; Wang CY; Wang YP
Hum Cell; 2023 Jul; 36(4):1535-1547. PubMed ID: 37145265
[TBL] [Abstract][Full Text] [Related]
11. Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway.
Jiang QG; Xiong CF; Lv YX
Mol Cell Biochem; 2021 Feb; 476(2):727-739. PubMed ID: 33201383
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
13. lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
Le F; Li HM; Lv QL; Chen JJ; Lin QX; Ji YL; Yi B
Mol Cell Endocrinol; 2022 Mar; 544():111551. PubMed ID: 34990740
[TBL] [Abstract][Full Text] [Related]
14. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
15. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
16. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
17. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer.
Jiao S; Li C; Hao Q; Miao H; Zhang L; Li L; Zhou Z
Nat Commun; 2017 Jan; 8():14058. PubMed ID: 28051067
[TBL] [Abstract][Full Text] [Related]
18. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway.
Lin QY; Qi QL; Hou S; Chen Z; Jiang N; Zhang L; Lin CH
Neoplasma; 2021 Sep; 68(5):1063-1071. PubMed ID: 34374294
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
20. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]